Answers are grounded in this paper and cite their sources.
Tratamiento actual del cncer de pulmn de clulas no pequeas con mutacin de EGFR: primera lnea y manejo a la progresin Current treatment of non-small cells lung cancer with EGFR mutation: first-line and management upon progression 10.20960/revcancer.
No takes yet. Share an insight, caveat, or question.
Gil‐Bazo et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: